SEC Tracker
Get the app

Strata Critical Medical SRTA

Strata Critical Medical Q1 FY26: revenue $67.4M, up 24%; diluted EPS $0.03

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Strata Critical Medical reported for Q1 FY26, the quarter ended Mar 31, 2026, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$67.4M+24% from $54.3M in Q1 FY2510-Q income statement, on EDGAR
  2. Net income$2.2MAgainst −$3.5M in Q1 FY2510-Q income statement, on EDGAR
  3. Diluted EPS$0.03Against −$0.04 in Q1 FY2510-Q income statement, on EDGAR
  4. Cash and cash equivalents$58.7M+69% from $34.8M in Q1 FY25Cash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
  5. Cash from operations$3.9MAgainst −$246K in Q1 FY2510-Q cash flow statement, on EDGAR

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Strata Critical Medical files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8000 and related industry codes: the same peer list as the financial tables.

  1. Talkspace TALK public float $393M, Jun 30, 2025
  2. DocGo DCGO public float $150M, Jun 30, 2025
  3. InnovAge Holding INNV public float $111M, Dec 31, 2025
  4. U S Physical Therapy USPH public float $737M, Jun 30, 2025
  5. LifeStance Health Group LFST public float $817M, Jun 30, 2025